Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-27T13:46:48.135Z Has data issue: false hasContentIssue false

A scoping review of adrenal vein sampling in practice settings: Applying an implementation science lens

Published online by Cambridge University Press:  19 November 2024

Heather Morris
Affiliation:
Health and Social Care Unit, Monash University, Melbourne, Victoria, Australia
Angela Melder*
Affiliation:
Health and Social Care Unit, Monash University, Melbourne, Victoria, Australia
Elisabeth Ng
Affiliation:
Centre for Endocrinology & Metabolism, Hudson Institute of Medical Research, Department of Endocrinology, Monash Health, Melbourne, Victoria, Australia
Helen Skouteris
Affiliation:
Health and Social Care Unit, Monash University, Melbourne, Victoria, Australia
Winston Chong
Affiliation:
Monash Health Radiology, Alfred Health Radiology, Central Clinical School, Monash University, Melbourne, Victoria, Australia
Jun Yang
Affiliation:
Endocrine Hypertension Group, Hudson Institute of Medical Research, Department of Medicine, Monash University, Melbourne, Victoria, Australia
*
Corresponding author: A. Melder; Email: angela.melder@monash.edu
Rights & Permissions [Opens in a new window]

Abstract

Adrenal vein sampling (AVS) is a complicated procedure requiring clinical expertise, collaboration, and patient involvement to ensure it occurs successfully. Implementation science offers unique insights into the barriers and enablers of service delivery of AVS. The primary aim of this review was to identify implementation components as described within clinical studies, that contribute to a successful AVS procedure. The secondary aim was to inform practice considerations to support the scale-up of AVS. A scoping review of clinical papers that discussed factors contributing to effective AVS implementation was included. A phased approach was employed to extract implementation science data from clinical studies. Implementation strategies were named and defined, allowing for implementation learnings to be synthesized, in the absence of dedicated research examining implementation process and findings only. Ten implementation components reported as contributing to a successful AVS procedure were identified. These components were categorized according to actions required pre-AVS, during AVS, and post-AVS. Using an implementation science approach, the findings of this review and analysis provide practical considerations to facilitate AVS service delivery design. Extracting implementation science information from clinical research has provided a mechanism that accelerates the translation of evidence into practice where implementation research is not yet available.

Type
Review Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Association for Clinical and Translational Science

Introduction

Primary aldosteronism (PA) is a common and potentially curable form of secondary hypertension, associated with increased cardiovascular morbidity when compared to essential hypertension [Reference Stowasser and Gordon1– Reference Monticone, D’Ascenzo and Moretti3]. PA results from aldosterone overproduction from either one or both adrenal glands, with differentiation being important as the former may be cured by surgery while the latter requires long-term medical treatment [Reference Funder, Carey and Mantero2]. PA was historically considered rare, however, more recent studies have identified its prevalence to be up to 14% in primary care, and close to 30% in referral centers [Reference Libianto, Russell and Stowasser4– Reference Turcu, Yang and Vaidya6]. As more clinicians screen for PA, there will be an increase in the demand for diagnostic tests, including a confirmatory test to demonstrate autonomous aldosterone production and adrenal vein sampling (AVS) to subtype PA as either unilateral (and curable with adrenal surgery) or bilateral (requiring lifelong medical therapy) [Reference Funder, Carey and Mantero2].

AVS is currently the gold standard investigation to subtype PA and identify surgically curable disease [Reference Funder, Carey and Mantero2] as CT imaging alone has low diagnostic accuracy [Reference Rossi, Crimì and Rossitto7]. AVS is an invasive, highly technical, and resource-intensive procedure, involving cannulation of bilateral adrenal veins most often through the femoral vein(s) in the groin for blood sampling to measure aldosterone and cortisol concentrations. Radiologist expertise and patient anatomy impact the duration of procedure and risk of complications such as bleeding, infection, and adrenal vein hemorrhage. There is also the risk of inconclusive results or procedural failure. There are strategies that have been associated with improved AVS success, defined by the ability to cannulate both adrenal veins and interpret the results for the assessment of aldosterone lateralization. These include having dedicated radiologists and using specific imaging and point-of-care assays to confirm adrenal vein cannulation success during the procedure [Reference Kocjan, Jensterle, Vidmar, Vrckovnik, Berden and Stankovic8– Reference Page, Taranto and Ramsay10]. The clinician performing AVS, often a radiologist, requires training, sufficient referrals for experience, and hospital resources including equipment, room availability, and support staff. Guidelines and protocols can offer support to clinicians performing AVS, however, there is a lack of consensus on the optimal methods for performing and interpreting AVS. AVS is available in limited tertiary referral centers and with few dedicated clinicians who perform the procedure, waiting lists can be long, thereby delaying the diagnosis and treatment of unilateral PA.

The issues described above outline the pre-, during, and post-AVS components that constitute the definition of a successful AVS procedure, each of which does not exist in isolation and is sequentially connected. However, these components, or barriers (or enablers) should be viewed as opportunities to generate change for which the field of implementation science has developed guidance (theories, models, and frameworks) and strategies to support this. Implementation science literature outlines antecedent factors to progress the introduction of a new practice, drug, or facility, as well as detailing processes for successful implementation. Using an implementation science approach to the problems seen with AVS allows for the characterization of what is needed to establish AVS successfully in a new setting and/or evaluate a current setting that is conducting AVS to determine if the ingredients for success are evident. This is a critical step as increased awareness of, and screening for PA will spur the uptake of AVS at scale, growing patients, clinicians, and hospitals that encounter the procedure. Currently, there is no implementation research around AVS, and the need to “raise the bar” through implementation science research in cardiology has been mentioned [Reference Vigen and Das11]. Hence, the primary aim of this research was to conduct a scoping review of studies that examined the conduct of AVS and implementation information that contributed to successful procedures. The secondary aim was to articulate considerations that support future scale-up.

Materials and methods

Design and approach

A scoping review of studies that described factors and processes involved in implementing and delivering AVS, in accordance with the established methodology [Reference Peters, Godfrey, Khalil, McInerney, Parker and Soares12] was conducted as a paucity of dedicated implementation research on AVS delivery was evident. In a novel approach that authors HM and AM devised, the review extracted information about implementation processes from clinical research papers that discussed AVS but did not explicitly investigate implementation concepts – a process termed by the authors as “implementation science gymnastics.” This process involved four phases, see Fig. 1, and reflects an overarching principle of applying implementation science thinking to unlock implementation information about supporting AVS.

Figure 1. Methodology used to extract implementation information from clinical research to inform new or scale-up of adrenal (AVS) vein sampling services.

Apply implementation science thinking to the clinical issue

An implementation science lens was applied to the examination of clinical studies. As a four-phased approach, the intention here was not to describe the clinical elements of AVS such as procedural details or result interpretation. These details are available in the guidelines and in published reviews [Reference Funder, Carey and Mantero2,Reference Kempers, Lenders and van Outheusden15– Reference Leung, Symonds and Hundemer17]. Rather, the implementation specialists on the authorship team [HM, AM, and HS] examined clinical AVS studies that identify critical features of a successful procedure that may inform the implementation processes. The authors’ knowledge of implementation informing this lens included frameworks such as the Consolidated Framework for Implementation Research [Reference Funder, Carey and Mantero2,Reference Damschroder, Reardon, Opra Widerquist and Lowery18], strategy lists such as Expert Recommendations for Implementing Change (ERIC) [Reference Powell, Waltz and Chinman13], competencies [Reference Metz, Louison, Burke, Albers and Ward19], drivers and timeframes [Reference Bertram, Blase and Fixsen20]. This approach was applied when reading clinical papers specifically to determine if any implementation knowledge was embedded such as barriers or enablers to a successful AVS outcome. This process was conducted in conjunction with clinicians who have expertise in AVS [Authors JY, WC, EN]. Although a complex activity, it was achievable by recruiting this competency and engaging with an implementation specialist in a specific research team.

Phase 1 – Consider clinical area: search strategy to identify AVS-Related research

Phase 1 identified the clinical area where implementation information was needed. This involved a search of the literature using a systematic methodology. Three databases, PubMed, Ovid Medline, and CINAHL, were searched with no date limit until January 2023. The search strategy for Ovid Medline is detailed in Table 1 and was translated for the other databases included. The inclusion criteria are also outlined further in Table 1. Abstracts were excluded if: 1) they were not relevant to AVS delivery including its use and success (e.g. focused on other procedures associated with PA or screening programs); and 2) there was no description of implementation strategies used to support an effective AVS procedure. Papers were included if they described both the study of AVS use and an implementation factor that impacted its success, which may be a clinical tool or method (such as CT imaging) or process-related (such as training [Reference Powell, Waltz and Chinman13]). One hundred percent agreement was obtained between authors via discussion and consensus as to the papers included in the review for data extraction.

Table 1. Search terms and inclusion criteria for the scoping review

A systematic quality assessment was not conducted. Given the main objective was to understand implementation factors described in the successful delivery of AVS, rather than seeking confidence in AVS itself, individual study quality was not considered relevant to this review. Existing systematic reviews have confirmed the efficacy of AVS in determining the laterality of disease [Reference Quencer14,Reference Kempers, Lenders and van Outheusden15].

Phase 2 – Describe implementation themes (data extraction from clinical studies)

Implementation information that emerged from the studies was grouped into themes. These themes were categorized by consensus between data extractors authors HM and AM and labeled implementation components and later confirmed by clinicians and authors [EN, JY]. They were then mapped using Proctor et al.’s (2013) framework for specifying and reporting implementation strategies [Reference Proctor, Powell and McMillen21], where the themes were named, defined, and specified. To specify the components the following information was extracted: the actors who enact the component, e.g., clinicians involved in undertaking the clinical procedure or supporting the delivery of a service; the action – the specific actions, steps, or processes, e.g., the clinical techniques applied; the action target, the unit of analysis for measuring implementation outcomes, e.g., completion of a task or procedure; temporality, when the strategy is used, e.g., timing of when to undertake a task or procedure; dose, e.g., how many procedures must be undertaken at any one point or the number of procedures to undertaken per clinician, frequency of use; implementation outcome affected (appropriateness, adoption, acceptability, feasibility, fidelity, cost, penetration, and sustainability); and its justification. Extracting data using this framework enabled a clear description of aspects needed to adopt AVS into new locations and sustain it within existing settings [Reference Proctor, Powell and McMillen21].

Phase 3 - Categorize details to facilitate real-world implementation

The data from the implementation components were then selected for their alignment with the ERIC taxonomy (Powell 2015). These are 73 discrete evidence-based strategies that promote the replication and advancement of implementation science, to strengthen the scale-up and translation of evidence into practice [Reference Powell, Waltz and Chinman13] (Nathan 2022). This phase enabled the articulation of implementation components presently used in the successful completion of AVS. The consistent and established taxonomy facilitated the considerations for implementation planning needed for phase 4.

Phase 4 - Present information for implementation planning

A set of considerations were devised through thematic evidence synthesis of the extracted data, using the Proctor Framework (Proctor 2013). These considerations enable decision-making with the right information, invite the system to think about the actors vital for effective AVS completion, support cost factors that impact effective implementation, and will provide practical insights for future implementation planning.

Results

The search returned 1316 articles, of which 20 were included in the final review [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22Reference Chayovan, Limumpornpetch and Hongsakul41] published from 2009 to 2023. Authors AM and HM each screened 50% of the abstracts and 100% of the full-text papers. One paper was originally published in Chinese (the abstract was published in English) and translation software was used [Reference Lin, Luo, Liu, Jiang and Hu30]. No other paper was originally published in another language other than English that we found. In the second phase authors HM and AM were the most flexible in their “implementation science gymnastics.” There was much discussion, interpretation and (re)examination of the literature between authors as it was believed that this approach would enable the collection of best available evidence. Particularly in light of the fact that no implementation studies exist about AVS. By applying an implementation science lens to clinical research about successful AVS procedures, a compilation of issues, barriers, and enablers was identified. Those that play a specific role in the success or failure of the procedure were identified, along with solutions and suggestions for the better implementation of AVS in existing or new services.

Data were thematically grouped to form ten implementation components that aligned before, during, and after AVS. Fig. 2 presents a conceptual model of these components and how they are related.

Figure 2. Conceptual model for successful adrenal vein (AVS) sampling.

Conduct of AVS and implementation information

The Proctor 2013 framework was used to guide data extracted (see Supplementary Table 1) that are described below. This framework was developed in response to the need for clarity around specific details implementation strategies. Here, we present the details about implementation information that contributed to successful AVS procedures. Whilst the implementation components identified were not strategies per say, the framework provided a structure to unpack the details including the justification for the component.

Pre-AVS

Developing technical skill

The learning curve for AVS proficiency is approximately 20–30 procedures per radiologist, [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22,Reference Kądziela, Prejbisz and Michałowska27,Reference Lin, Luo, Liu, Jiang and Hu30] and to maintain this skill, a minimum of 15–20 procedures annually has been suggested [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22,Reference So, Leung, Chin and Kline34]. In light of these numbers, hospitals over the last decade have altered their approach to upskilling practitioners doing AVS: 1) by narrowing the number of clinicians to one or two people [Reference Jakobsson, Farmaki, Sakinis, Ehn, Johannsson and Ragnarsson26,Reference Kądziela, Prejbisz and Michałowska27,Reference So, Leung, Chin and Kline34Reference Vonend, Ockenfels and Gao37,Reference Yoneda, Karashima and Kometani39,Reference Young and Stanson40]; or 2) referring patients to a larger center with more expertise [Reference Betz, Degenhart and Fischer24,Reference Vonend, Ockenfels and Gao37]. These measures enhance the procedure’s fidelity and sustainability.

Protocol

Papers included in this scoping review noted that operation protocols need to exist at the hospital level. One paper suggested that the endocrine society guidelines should instruct decisions about lateralization [Reference Umapathysivam, Morgan and Bischoff36] and another referred to a patient’s clinical characteristics for the need for AVS at all [Reference Fujii, Takeda and Kurihara25]. Apart from these studies, there was a lack of clarity about the inclusion of evidence-based guidelines into hospital-level protocols. There was a widely-held view, however, that a hospital guideline should be written collaboratively [Reference Betz, Degenhart and Fischer24], with representatives from many departments [Reference Betz, Degenhart and Fischer24,Reference Vonend, Ockenfels and Gao37,Reference Young and Stanson40,Reference Kocjan, Jensterle, Vidmar, Berden and Stankovic29,Reference Young and Stanson40]. This may enhance the speed of the protocol’s penetration throughout the relevant departments. The protocol may include specific instructions about staff and hospital procedures to restrict operator error or confusion [Reference Betz, Degenhart and Fischer24]. Collaboration with the referring physician was noted by So (2021) as important in two ways: 1) to support the referral pathways, preparation, and results interpretation; and 2) to support the inexperienced referring physician in preparing the patient correctly (such as avoiding some medications) [Reference So, Leung, Chin and Kline34].

AVS suitability and procedure preparation

There was little consensus about preparation and confirmatory tests for AVS. The literature is clear on the inadequacy of imaging alone in determining the likelihood of unilateral PA and therefore the need for AVS [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22] with discordance between imaging and AVS results being as high as 73% [Reference Vonend, Ockenfels and Gao37]. An update of the Endocrine Society’s guidelines in 2016 included many factors around confirmatory testing and work-up. New parameters exist which, if met, could facilitate referral for AVS without confirmatory testing [Reference Vorselaars, van Beek and Suurd38]; however, the appropriateness of this needs to be considered. A recent multicentre study involving 435 people found that 40.7% (n = 177) of patients did not need confirmatory testing according to the guideline, but only 18.9% (n = 49) of patients that needed testing actually completed it [Reference Vorselaars, van Beek and Suurd38]. This suggests that the guideline is not being followed for confirmatory testing, and decisions about what tests to do and when are largely based on the clinician’s choice [Reference Vorselaars, van Beek and Suurd38]. The risk of overlooking evidence-based guidelines is an unnecessary AVS procedure which is a concern given cost implications for hospitals and the risk of procedural complications for patients [Reference Rossi, Barisa and Allolio32,Reference Vorselaars, van Beek and Suurd38]. Indeed the age [Reference Betz, Degenhart and Fischer24] or comorbidities [Reference Kocjan, Jensterle, Vidmar, Berden and Stankovic29] of some patients may contribute to a clinician’s decision about undergoing AVS or a surgical treatment option at all. Recent studies suggest that variance in confirmatory testing remains an issue to this day [Reference Leung, Symonds and Hundemer17,Reference Naruse, Murakami and Katabami42].

Patient voice and informed choice

Patients play a significant role in the conduct of AVS, with a recent study finding the main reason for not performing AVS on a patient was their refusal to participate [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22]. When considering the option of doing AVS, studies agreed it should only be done on patients who want a surgical cure [Reference Kocjan, Jensterle, Vidmar, Berden and Stankovic29,Reference Young and Stanson40], with one study revealing the main reason for refusing surgery post-AVS was a change of mind [Reference Kocjan, Jensterle, Vidmar, Berden and Stankovic29]. This suggests that better preparation is needed to support patients prior to doing AVS about what comes afterward. Cost and time may be saved through enhanced knowledge provision to the patient about the procedure [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22], outcomes, complications [Reference Vorselaars, van Beek and Suurd38], and effectiveness including the potential for repeating AVS should it fail [Reference So, Leung, Chin and Kline34]. Patients should feel supported to make an informed decision about undergoing AVS [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22], having a surgical cure post-procedure, and knowing that long-term medicinal treatment is an option [Reference Kocjan, Jensterle, Vidmar, Berden and Stankovic29].

Imaging

Imaging, including MRI and CT, was considered by the included studies as an important part of the pre-AVS phase, however, is not appropriate as the only test for. Whilst current guidelines recommend imaging to rule out adrenocortical carcinoma [Reference Jakobsson, Farmaki, Sakinis, Ehn, Johannsson and Ragnarsson26,Reference Kądziela, Prejbisz and Michałowska27], it is most frequently conducted to provide anatomical information to the radiologist about the right adrenal vein [Reference Kądziela, Prejbisz and Michałowska27,Reference Lin, Luo, Liu, Jiang and Hu30Reference Rossi, Barisa and Allolio32,Reference Tan, Puar and Swaminathan35,Reference Vonend, Ockenfels and Gao37]. One study reported that use of pre-AVS contrast-enhanced CT scans enabled operators to visualize the left adrenal vein in 98% of cases and the right in 95% of cases, contributing to technical success [Reference Morita, Yamazaki, Sonoyama, Nishina, Ichihara and Sakai31] and procedural fidelity. Another study that described the learning curve required to perform AVS without use of prior imaging indicated that a clinician who had completed between 50–60 procedures could do this adequately [Reference Kądziela, Prejbisz and Michałowska27].

During AVS

Procedural support

For clinicians training to perform AVS, having access to support during a procedure is critical to the timeliness of the learning curve, and enhances fidelity to the procedure. This support may be in the form of mentoring and/or technological support, such as Rapid Cortisol Testing and Cone beam CT discussed below. Support during the procedure by a skilled clinician with technical expertise was recognized by several studies as an important contributor to procedural success, attributable in part to support with planning, guidance with adrenal vein cannulation, and moral support [Reference Betz, Degenhart and Fischer24,Reference Jakobsson, Farmaki, Sakinis, Ehn, Johannsson and Ragnarsson26,Reference Morita, Yamazaki, Sonoyama, Nishina, Ichihara and Sakai31]. Having a system of support may increase the adoption of the procedure within a new service and support the sustainability of the program.

Rapid cortisol testing

Eight studies referred to the use of rapid cortisol assay (RCA) (Serum/plasma or point of care) as an important tool for the confirmation of adrenal vein cannulation [Reference Betz, Degenhart and Fischer24,Reference Jakobsson, Farmaki, Sakinis, Ehn, Johannsson and Ragnarsson26,Reference Lin, Luo, Liu, Jiang and Hu30,Reference Siracuse, Clarke and Kabutey33,Reference Tan, Puar and Swaminathan35Reference Vonend, Ockenfels and Gao37,Reference Yoneda, Karashima and Kometani39], contributing to a reduction in failed cannulation during the training phase [Reference Betz, Degenhart and Fischer24]. Timing can become an issue. Point of care RCA can be done within a few minutes at the bedside while laboratory-based RCA requires different preparation [Reference Tan, Puar and Swaminathan35], and the proximity of the lab means the results can take up to 30–60 minutes to return [Reference Betz, Degenhart and Fischer24]. One study suggested that lower-income countries such as China may find it difficult to employ this test due to the number of institutions with RCA capacity [Reference Lin, Luo, Liu, Jiang and Hu30].

Cone Beam Computer Tomography (CBCT)

The use of CBCT during the procedure was only mentioned in two papers [Reference Lin, Luo, Liu, Jiang and Hu30,Reference Tan, Puar and Swaminathan35]. One paper proposed it could serve as an alternative for low-resource hospitals that do not have access to RCAs [Reference Lin, Luo, Liu, Jiang and Hu30]. Clinicians would need to consider the appropriateness or feasibility of this test for use during AVS when RCA is available.

Communication and collaboration

A number of communication and collaboration systems need to be in place to ensure that AVS occurs effectively and with the least avoidable errors. Papers identified specimen handling protocols [Reference So, Leung, Chin and Kline34] or safeguards [Reference Young and Stanson40] for test tube labeling including the use of printed labels to avoid mistakes [Reference Tan, Puar and Swaminathan35]. Also mentioned was a collaborative approach needed for reporting preferences, such as in absolute values [Reference Tan, Puar and Swaminathan35] or in a particular table [Reference Kline and Holmes28] An acceptable and communicated agreement between departments and clinicians about processes is needed to reduce avoidable errors and increase adoption.

Post-AVS

Results interpretation

Once AVS has been conducted, biochemical results are analyzed to determine the success of cannulation (using the selectivity index) and if the source of PA is on one side or both (lateralization index). While the Endocrine Society guidelines offer advice for selectivity and lateralization indices, one study noted that hospitals use their own guidelines and criteria [Reference Rossi, Barisa and Allolio32] with an overall lack of consensus on how AVS should be interpreted [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22]. In fact, it has been noted that recommendations for AVS or adrenalectomy are at times, not made using the guidelines [Reference Auchus, Michaelis and Wians23]. The reasons for this remain unclear. Perhaps it is because a clinician must combine several pieces of information including imaging and biochemistry results, patient demographics, and comorbidities, along with the AVS outcome to make a decision about appropriate treatment options for the patient [Reference Kline and Holmes28,Reference So, Leung, Chin and Kline34]. These factors become quite important as being more liberal or restrictive with a selectivity index or lateralization index can change the success rate and lateralization rate of AVS markedly [Reference Vonend, Ockenfels and Gao37].

Implementation strategies and considerations for practice

The ERIC strategies employed by different hospitals and clinicians as they undertook the implementation components are spelled out in Supplementary Table 2. ERIC strategies are effective in improving the implementation of a clinical intervention [Reference Powell, Waltz and Chinman13]. Embedded within the clinical research papers were 13 different methods that had been employed by hospitals or clinicians as they implemented AVS for success. In particular, these methods focus on knowledge translation (such as “capture and share local knowledge”) and development (such as, “prepare patients/consumers to be active participants”). Other strategies may have been used that were not reported in the literature, which contributed to change. Using the data presented in the scoping review and clinical expertise from our authorship team, a list of considerations (“what” needs to be implemented and “how”) for each implementation component was produced to support the decision-making of hospitals or centers considering the introduction, modification, or upscale of an AVS service, see Table 2.

Table 2. Considerations to support decision-making around adrenal vein sampling (AVS)

Discussion

This scoping review has detailed implementation components that support the successful completion of AVS while also providing considerations for healthcare policymakers and administrators. The fact that there are several components aligns with Tan (2022), who note that multiple efforts to improve AVS success were what worked and not “one” thing [Reference Tan, Puar and Swaminathan35]. The Proctor (2013) framework requiring researchers to name, define, and specify the implementation components was utilized, which were then graphically represented in a conceptual model (see Fig. 2). There was a clear volume of evidence about the pre-AVS implementation components such as developing technical skill, use of CT imaging and having a local AVS hospital protocol lead to increased AVS success. These, in conjunction with procedural support and communication during AVS, minimize avoidable mistakes and enhance operator skills. There was further evidence to support the need for in-procedure support by an expert for clinicians on a learning journey. In addition, the use of rapid cortisol testing to confirm the correct cannulation of the adrenal veins offers a clear avenue for reduced AVS failure and repetition. Together these components increase the chances of successful completion of AVS. Evidence for the best way to use other implementation components (patient voice and choice; AVS suitability and procedure preparation; CBCT; results interpretation), which are needed for procedure preparation and outcome analysis, was less clear. This was due to many factors including the natural variability in patients and their comorbidities; clinicians’ use of evidence-based guidelines in concert with their practice-based expertise; views from multidisciplinary colleagues to inform decision-making; and imaging equipment availability within the hospital setting. This suggests that more information is needed to inform the “how” of best implementation when variability is unavoidable.

A marked increase in AVS success was demonstrated when hospitals actively minimized the number of interventional radiologists doing AVS to one or two clinicians, due to the volume of procedures required to be proficient [Reference Jakobsson, Farmaki, Sakinis, Ehn, Johannsson and Ragnarsson26,Reference Rossi, Barisa and Allolio32,Reference So, Leung, Chin and Kline34]. Since few procedures are done per month even in high volume centers, and maintenance of expertise requires 1522 –2026 procedures annually, the decision to consolidate expertise into one or two highly skilled operators was logical. Conversely, only one study noted that multiple surgeons should be involved to ensure that expertise is developed across their staff [Reference Siracuse, Clarke and Kabutey33]. As it may take 2–3 years to reach 30 procedures (the learning curve for AVS) depending on hospital volume, referral rates, and other factors, there must be systems of support, training, and feedback in place to ensure staff can develop and/or maintain the AVS learning curve [Reference Hopper, Jamison and Lewis43]. While this requires a long-term focus from hospital administrators, it will strengthen the fidelity of the procedure and potentially minimize costs from failed procedures.

The success of AVS is essentially based on the selectivity index which tells us whether the catheter was in the adrenal vein. Hence, factors that confound the selectivity index, such as concurrent autonomous cortisol secretion [Reference Buffolo, Pieroni and Ponzetto44], the use of adrenocorticotropic hormone during AVS [Reference Liu, Zhang and Yang45,Reference Yozamp, Hundemer and Moussa46], or the use of sedation [Reference Yang, Libianto and Lau47], may cause an apparent failure of cannulation. As new information emerges about the AVS procedure and outcomes [Reference Marzano, Husain-Syed, Reis, Ronco and Zanella48,Reference Yang, Chang and Lee49], there will continue to be variation across hospitals and centers about the indices that are used (as opposed to recommended). It therefore becomes important for clear justifications of clinical decisions made, with regular reviews of new evidence and where relevant, and updating local hospital protocols to ensure that implementation is based on the best evidence.

As centers initiate and optimize patient engagement in research and quality improvement initiates related to AVS delivery, there is much to learn from an implementation perspective so that AVS can be an acceptable, cost-effective, and feasible procedure. Little discussion in the identified papers was about the patient as an active participant in their AVS experience. Understandably the patient was not the focus of the papers and any note of their participation was related to the procedure itself (such as timing of the day [Reference So, Leung, Chin and Kline34] or adjustments to medications prior to [Reference Araujo-Castro, Paja Fano and Gonzalez Boillos22]) or their interest in surgery post-AVS. In one study patient refusal was the major reason for not doing surgery [Reference Kocjan, Jensterle, Vidmar, Berden and Stankovic29], and since the rationale for doing AVS is a surgical cure, engaging the patient early and often about their choices is a vital part. Yet, little research on patient views, experiences, or engagement with PA or AVS is available to inform how best to support clinicians in their care. One study found patient knowledge of the condition and the procedure is inadequate, and their journey towards a PA diagnosis is a major barrier to treatment [Reference Ragnarsson, Muth, Johannsson, Gkaniatsa, Ung and Jakobsson50].

Implementation components and considerations for future implementation and scale Up

This review outlined implementation components that service providers can utilize in their establishment of AVS in a new service, to monitor and assess the progress of their AVS implementation. The ERIC strategies described in the reviewed literature frequently referenced readiness, training, supervision and assistance, and harnessing local knowledge, likely due to AVS being a complicated procedure. Future implementation research into the scale-up of AVS should investigate the ERIC strategies more deeply to identify other strategies that may generate a greater implementation effect.

Working with the named components from Fig. 2, the practical aspects drawn from clinical research for scaling or implementing successful AVS were studied. From this, considerations for future AVS implementation and scale-up were developed to support hospital administrators and policymakers. Indeed, a crucial factor is to have the radiologists, biochemists, and endocrinologists review the evidence and decide collaboratively what is possible to adopt in their own service. These considerations are by no means complete and should prompt challenging conversations with multidisciplinary voices including patients to enhance the chances of success. As this review points out, there are many factors that contribute to AVS success and while certainly there will be failures, the findings of this review offer ways to mitigate and strengthen the factors that contribute to its success. These considerations should be examined in the light of the local context and adaptions based on the availability or constraints of human, equipment and financial resources should be clearly justified, but also revisited as systems and resources change.

Strengths and Limitations

The approach of extracting implementation science information from clinical research is a mechanism to accelerate the translation of evidence into practice where implementation research is not yet available. This method, though likened to ‘implementation science gymnastics’ due to the extensive discussion, application, translation, and thoughtful engagement with the literature it required, provided an opportunity to explore the translational potential of clinical research. It could inform future implementation research in a more directed and focused manner. Additionally, it leveraged the knowledge from existing implementation science frameworks as a foundation. Expanding implementation science use within the clinical setting and promoting high-quality reporting of clinical research [Reference Turcu, Yang and Vaidya6,Reference Hoffmann, Glasziou and Boutron51] can only hasten the translation of knowledge into practice. Of note, a prerequisite for enabling our approach was the considerable information about implementation activities present in the clinical literature on delivering AVS. However, there are limitations to translating clinical information into implementation science concepts. Potential issues include misunderstanding or misattribution, overlooking important factors, and author bias. To mitigate these risks, regular multidisciplinary meetings with context experts and authors JY, EN, and WC were instituted.

Our search strategy initially included the acronym “AVS” as a search term. Its high frequency of use in the literature (see, for example, automated vehicles, atrial ventricular syncope) tripled the number of results to screen. Thus, to narrow the scope of our search, this was omitted; however, it is possible papers were missed due to this approach. Of the studies found, all but one (a randomized study [Reference Yoneda, Karashima and Kometani39]) were retrospective in nature. The retrospective study design comes with serious biases that affect the reliability of study findings [Reference Talari and Goyal52]. Across the included retrospective studies, we observed selection bias with patients included in the retrospective studies which was acknowledged by the authors. The lack of prospective design means that information biases can affect the measurement of clinical outcomes which are based on existing records in the retrospective studies. In addition, the implementation evidence was based on the experiences of others and only of those that were described. It is likely that other effective methods were utilized to enhance AVS success but not published.

Conclusion

This scoping review examined the implementation components found in clinical research papers that support the successful conduct of AVS. Using a novel approach of data extraction informed by implementation science frameworks, components that support successful AVS procedures were named, defined, and specified. In contrast to guidelines that report evidence to support best practice, the rationale and implementation of these practices are often unreported, yet this information is necessary to enhance AVS scale-up. The findings provide practical insights and recommendations to facilitate service delivery and design. This will enhance the effectiveness of a health service providing AVS, potentially saving resources whilst improving patient outcomes.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/cts.2024.656.

Authors contributions

HM and AM: Contributed to the conceptualization, methodology, literature search and screening, synthesis and analysis, investigation, and co-writing (original draft, review, and editing). EG, HS, WC, and JY: Contributed to conceptualization, clinical content, and sense-making of clinical implementation context. They were also involved in co-writing (review and editing). HS and JY: provided oversight and leadership responsibility for the research activity planning and execution.

Funding statement

The research was funded by the Australian Medical Research Future Fund (MRFAR000172).

Competing interests

All authors have no issues relating to journal policies; we have no potential competing interests to declare.

References

Stowasser, M, Gordon, RD. Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney. Physiol Rev. 2016;96: 13271384. doi: 10.1152/physrev.00026.2015 Google Scholar
Funder, JW, Carey, RM, Mantero, F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101: 18891916. doi: 10.1210/jc.2015-4061 Google Scholar
Monticone, S, D’Ascenzo, F, Moretti, C, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6: 4150. doi: 10.1016/s2213-8587(17)30319-4 Google Scholar
Libianto, R, Russell, GM, Stowasser, M, et al. Detecting primary aldosteronism in Australian primary care: A prospective study. Med J Australia. 2022;216: 408412. doi: 10.5694/mja2.51438 Google Scholar
Käyser, SC, Dekkers, T, Groenewoud, HJ, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis. J Clin Endocrinol Metab. 2016;101: 28262835. doi: 10.1210/jc.2016-1472 Google Scholar
Turcu, AF, Yang, J, Vaidya, A. Primary aldosteronism — a multidimensional syndrome. Nat Rev Endocrinol. 2022;18: 665682. doi: 10.1038/s41574-022-00730-2 Google Scholar
Rossi, GP, Crimì, F, Rossitto, G, et al. Identification of surgically curable primary aldosteronism by imaging in a large, multiethnic international study. J Clin Endocrinol Metab. 2021;106: e4340e4349. doi: 10.1210/clinem/dgab482 Google Scholar
Kocjan, T, Jensterle, M, Vidmar, G, Vrckovnik, R, Berden, P, Stankovic, M. Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience. Radiol Oncol. 2020;54: 409418. doi: 10.2478/raon-2020-0052 Google Scholar
Maruyama, K, Sofue, K, Okada, T, et al. Advantages of intraprocedural unenhanced CT during adrenal venous sampling to confirm accurate catheterization of the right adrenal vein. Cardiovasc Intervent Radiol. 2019;42: 542551. doi: 10.1007/s00270-018-2135-5 Google Scholar
Page, MM, Taranto, M, Ramsay, D, et al. Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement. Ann Clin Biochem. 2018;55: 588592. doi: 10.1177/0004563218760352 Google Scholar
Vigen, R, Das, SR. Raising the Bar for Implementation Science. Circulation. 2023;147:15151517. doi: 10.1161/CIRCULATIONAHA.123.064671 Google Scholar
Peters, MDJ, Godfrey, CM, Khalil, H, McInerney, P, Parker, D, Soares, CB. Guidance for conducting systematic scoping reviews. JBI Evidence Implementation. 2015;13: 141146. doi: 10.1097/xeb.0000000000000050 Google Scholar
Powell, BJ, Waltz, TJ, Chinman, MJ, et al. A refined compilation of implementation strategies: Results from the expert recommendations for implementing change (ERIC) project. Implement Sci. 2015;10: 21. doi: 10.1186/s13012-015-0209-1 Google Scholar
Quencer, KB. Adrenal vein sampling: Technique and protocol, a systematic review. CVIR Endovascular 2021;4: 38.Google Scholar
Kempers, M, Lenders, J, van Outheusden, L, et al. Systematic review: Diagnostic procedures to differentiate unilateral from bilateral adrenal Abnormality in primary aldosteronism. Ann Intern Med. 2009;151: 329337.Google Scholar
Hernandez, MF, Bhalla, V. Underdiagnosis of primary aldosteronism: A review of screening and detection. Am J Kidney Dis. 2023;82: 333346. doi: 10.1053/j.ajkd.2023.01.447 Google Scholar
Leung, AA, Symonds, CJ, Hundemer, GL, et al. Performance of confirmatory tests for diagnosing primary aldosteronism: A systematic review and meta-analysis. Hypertension 2022;79: 18351844.Google Scholar
Damschroder, LJ, Reardon, CM, Opra Widerquist, MA, Lowery, J. Conceptualizing outcomes for use with the consolidated framework for implementation research (CFIR): The CFIR outcomes addendum. Implement Sci. 2022;17: 110.Google Scholar
Metz, A, Louison, L, Burke, K, Albers, B, Ward, C. Implementation support practitioner profile: Guiding principles and core competencies for implementation practice. Chapel Hill, NC: National Implementation Research Network, University of North Carolina at Chapel Hill; 2020.Google Scholar
Bertram, RM, Blase, KA, Fixsen, DL. Improving programs and outcomes: implementation frameworks and organization change. Res Social Work Prac. 2015;25: 477487.Google Scholar
Proctor, EK, Powell, BJ, McMillen, JC. Implementation strategies: Recommendations for specifying and reporting. Implement Sci. 2013;8: 139. doi: 10.1186/1748-5908-8-139 Google Scholar
Araujo-Castro, M, Paja Fano, M, Gonzalez Boillos, M, et al. Adrenal venous sampling in primary aldosteronism: Experience of a spanish multicentric study (Results from the SPAIN-ALDO register). Endocrine. 2022;78: 363372.Google Scholar
Auchus, RJ, Michaelis, C, Wians, FH, et al. Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg. 2009;249: 318321.Google Scholar
Betz, MJ, Degenhart, C, Fischer, E, et al. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol. 2011;165: 301306.Google Scholar
Fujii, Y, Takeda, Y, Kurihara, I, et al. Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan. J Hum Hypertens. 2020;34: 3442.Google Scholar
Jakobsson, H, Farmaki, K, Sakinis, A, Ehn, O, Johannsson, G, Ragnarsson, O. Adrenal venous sampling: The learning curve of a single interventionalist with 282 consecutive procedures. Diagn Interv Radiol. 2018;24:89.Google Scholar
Kądziela, J, Prejbisz, A, Michałowska, I, et al. A single-centre experience of the implementation of adrenal vein sampling procedure: The impact on the diagnostic work-up in primary aldosteronism. Kardiologia Polska (Polish Heart Journal) 2017;75: 2834.Google Scholar
Kline, G, Holmes, DT. Adrenal venous sampling for primary aldosteronism: Laboratory medicine best practice. J Clin Pathol. 2017;70: 911916.Google Scholar
Kocjan, T, Jensterle, M, Vidmar, G, Berden, P, Stankovic, M. Adrenal vein sampling for primary aldosteronism: A 15-year national referral center experience. Radiol Oncol. 2020;54: 409418.Google Scholar
Lin, Y, Luo, J, Liu, S, Jiang, Q, Hu, C. Learning curve of adrenal vein sampling. Zhong nan da xue xue bao Yi xue ban= Journal of Central South University Medical Sciences 2021;46: 9961002.Google Scholar
Morita, S, Yamazaki, H, Sonoyama, Y, Nishina, Y, Ichihara, A, Sakai, S. Successful adrenal venous sampling by non-experts with reference to CT images. Cardiovasc Inter Rad. 2016;39: 10011006.Google Scholar
Rossi, GP, Barisa, M, Allolio, B, et al. The adrenal vein sampling international study (AVIS) for identifying the major subtypes of primary aldosteronism. The Journal of Clinical Endocrinology 2012;97: 16061614.Google Scholar
Siracuse, JJ, Clarke, NC, Kabutey, N, et al. Adrenal venous sampling for hyperaldosteronism: the vascular surgeon experience. J Vasc Surg. 2013;57: 62S63S.Google Scholar
So, C, Leung, A, Chin, A, Kline, G. Adrenal venous sampling in primary aldosteronism: Lessons from over 600 single-operator procedures. Clin Radiol. 2022;77: e170e179.Google Scholar
Tan, M-O, Puar, THK, Swaminathan, SK, et al. Improved adrenal vein sampling from a dedicated programme: Experience of a low-volume single centre in Singapore. Singap Med J. 2022;63: 111116.Google Scholar
Umapathysivam, MM, Morgan, B, Bischoff, C, et al. Intraprocedural cortisol testing improves adrenal vein cannulation success and diagnostic accuracy in assessment of primary aldosteronism, in a medium throughput centre. J Hum Hypertens. 2022;37: 15.Google Scholar
Vonend, O, Ockenfels, N, Gao, X, et al. Adrenal venous sampling: Evaluation of the german conn’s registry. Hypertension 2011;57: 990995. doi: 10.1161/hypertensionaha.110.168484 Google Scholar
Vorselaars, WM, van Beek, D-J, Suurd, DP, et al. Adrenalectomy for primary aldosteronism: Significant variability in work-up strategies and low guideline adherence in worldwide daily clinical practice. World J Surg., 2020;44: 19051915.Google Scholar
Yoneda, T, Karashima, S, Kometani, M, et al. Impact of new quick gold nanoparticle-based cortisol assay during adrenal vein sampling for primary aldosteronism. The Journal of Clinical Endocrinology & Metabolism 2016;101: 25542561. doi: 10.1210/jc.2016-1011 Google Scholar
Young, WF, Stanson, AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol. 2009;70: 1417.Google Scholar
Chayovan, T, Limumpornpetch, P, Hongsakul, K. Success rate of adrenal venous sampling and predictors for success: A retrospective study. Polish Journal of Radiology 2019;84:136141.Google Scholar
Naruse, M, Murakami, M, Katabami, T, et al. International multicenter survey on screening and confirmatory testing in primary aldosteronism. Eur J Endocrinol. 2023;188: 125134. doi: 10.1093/ejendo/lvac002 Google Scholar
Hopper, AN, Jamison, MH, Lewis, WG. Learning curves in surgical practice. Postgrad Med J. 2007;83: 777779. doi: 10.1136/pgmj.2007.057190 Google Scholar
Buffolo, F, Pieroni, J, Ponzetto, F, et al. Prevalence of cortisol cosecretion in patients with primary aldosteronism: Role of metanephrine in adrenal vein sampling. The Journal of Clinical Endocrinology & Metabolism 2023;108: e720e725. doi: 10.1210/clinem/dgad179 Google Scholar
Liu, W, Zhang, J, Yang, Y, et al. Effect of adrenocorticotropic hormone stimulation during simultaneous bilateral adrenal vein sampling in primary aldosteronism. Horm Metab Res., 2021;53: 364370. doi: 10.1055/a-1498-6958 Google Scholar
Yozamp, N, Hundemer, GL, Moussa, M, et al. Adrenocorticotropic hormone-stimulated adrenal venous sampling underestimates surgically curable primary aldosteronism: A retrospective cohort study and review of contemporary studies. Hypertension 2021;78: 94103. doi: 10.1161/HYPERTENSIONAHA.121.17248 Google Scholar
Yang, J, Libianto, R, Lau, KK, et al. Impact of intraprocedural sedation on adrenal vein sampling without corticotropin stimulation. Radiology 2022;304: 716718.Google Scholar
Marzano, L, Husain-Syed, F, Reis, T, Ronco, C, Zanella, M. Assessment of performance of stratum-specific likelihood ratios of the aldosteronoma resolution score for predicting hypertension cure after adrenalectomy for primary aldosteronism: A systematic review and meta-analysis. J Hum Hypertens., 2022;37: 532541. doi: 10.1038/s41371-022-00731-8 Google Scholar
Yang, YH, Chang, YL, Lee, BC, et al. Strategies for subtyping primary aldosteronism. J Formos Med Assoc. 2024;123: S114S124. doi: 10.1016/j.jfma.2023.05.004 Google Scholar
Ragnarsson, O, Muth, A, Johannsson, G, Gkaniatsa, E, Ung, EJ, Jakobsson, S. Illness perspectives in patients with primary aldosteronism. Plos One 2022;17: e0277902.Google Scholar
Hoffmann, TC, Glasziou, PP, Boutron, I, et al. Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide. Bmj. 2014;348: g1687g1687.Google Scholar
Talari, K, Goyal, M. Retrospective studies-utility and caveats. J R Coll Physicians Edinb. 2020; 50: 398402.Google Scholar
Figure 0

Figure 1. Methodology used to extract implementation information from clinical research to inform new or scale-up of adrenal (AVS) vein sampling services.

Figure 1

Table 1. Search terms and inclusion criteria for the scoping review

Figure 2

Figure 2. Conceptual model for successful adrenal vein (AVS) sampling.

Figure 3

Table 2. Considerations to support decision-making around adrenal vein sampling (AVS)

Supplementary material: File

Morris et al. supplementary material 1

Morris et al. supplementary material
Download Morris et al. supplementary material 1(File)
File 72.3 KB
Supplementary material: File

Morris et al. supplementary material 2

Morris et al. supplementary material
Download Morris et al. supplementary material 2(File)
File 27.7 KB